Enrolling MASH - Metabolic Dysfunction-Associated Steatohepatitis Drug: HU6 Other: Placebo EASi-PROTKT - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease
Z., Boutagayout, A., Rehali, M., Jaadan, H., El Housni, Z., et al
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation
The pharmacy adheres to strict manufacturing practices, ensuring that all peptides are produced in compliance with FDA regulations and undergo comprehensive third-party testing to verify their potency and purity